Affiliation:
1. Department of Comparative Medicine Stanford University Stanford California USA
2. Department of Mathematics Naresuan University Phitsanulok Thailand
3. University of California Merced California USA
4. Murdoch University Murdoch Western Australia Australia
5. Department of Comparative Diagnostic & Population Medicine University of Florida College Gainesville Florida USA
Abstract
AbstractBackgroundAtipamezole, an α‐2 adrenergic receptor antagonist, reverses the α‐2 agonist anesthetic effects. There is a dearth of information on the physiological effects of these drugs in cynomolgus macaques (Macaca fascicularis). We assessed atipamezole's physiologic effects. We hypothesized atipamezole administration would alter anesthetic parameters.MethodsFive cynomolgus macaques were sedated with ketamine/dexmedetomidine intramuscularly, followed 45 min later with atipamezole (0.5 mg/kg). Anesthetic parameters (heart rate, blood pressure [systolic (SAP), diastolic (DAP), and mean (MAP) blood pressure], body temperature, respiratory rate, and %SpO2) were monitored prior to and every 10 min (through 60 min) post atipamezole injection.ResultsWhile heart rate was significantly increased for 60 min; SAP, DAP, MAP, and temperature were significantly decreased at 10 min.ConclusionsThis study indicates subcutaneous atipamezole results in increased heart rate and transient blood pressure decrease. These findings are clinically important to ensure anesthetist awareness to properly support and treat patients as needed.
Subject
General Veterinary,Animal Science and Zoology
Reference25 articles.
1. New World and Old World Monkeys
2. Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective α2-Adrenoceptor Antagonist
3. Yohimbine: a pharmacological probe for study of the alpha 2‐adrenoreceptor;Pharmacol Rev,1983
4. Pharm profile: atipamezole;Bahri LE;Pharmacol Compendium,2008
5. Highly selective and specific antagonism of central and peripheral alpha 2‐adrenoceptors by atipamezole;Virtanen R;Arch Int Pharmacodyn Ther,1989